Holen Sie sich die Stockscreener-App
18.06
3.14%
0.5633
Schlusskurs vom Vortag:
$17.50
Offen:
$17.72
24-Stunden-Volumen:
143.51K
Relative Volume:
1.48
Marktkapitalisierung:
$960.86M
Einnahmen:
-
Nettoeinkommen (Verlust:
-
KGV:
-
EPS:
-
Netto-Cashflow:
-
1W Leistung:
+15.26%
1M Leistung:
+0.00%
6M Leistung:
+0.00%
1J Leistung:
+0.00%
1-Tages-Spanne:
$17.32
$18.25
1-Wochen-Bereich:
$15.52
$18.25
52-Wochen-Spanne:
$14.85
$19.17
Seaport Therapeutics Inc Stock (SPTX) Company Profile
Firmenname
Seaport Therapeutics Inc
Sektor
Branche
Telefon
-
Adresse
-
Compare SPTX vs VRTX, REGN, ARGX, ALNY, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
SPTX
Seaport Therapeutics Inc
|
18.12 | 927.99M | 0 | 0 | 0 | 0.00 |
VRTX
Vertex Pharmaceuticals Inc
|
436.53 | 110.28B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
635.05 | 66.98B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
806.75 | 50.15B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
295.32 | 39.71B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
154.77 | 32.22B | 742.00K | -1.37B | -1.07B | -7.0731 |
Seaport Therapeutics Inc Aktie (SPTX) Neueste Nachrichten
SPTX Initiated Coverage by JP Morgan -- Price Target Set at $42.00 - GuruFocus
Seaport Therapeutics (SPTX) Stock Forecast and Price Target 2026 - MarketBeat
Leerink initiates Seaport Therapeutics stock with outperform rating - Investing.com
Stifel Initiates Seaport Therapeutics at Buy With $30 Price Target - marketscreener.com
Leerink initiates Seaport Therapeutics stock with outperform rating By Investing.com - Investing.com Canada
Citigroup Initiates Seaport Therapeutics at Buy With $35 Price Target - marketscreener.com
Stifel initiates Seaport Therapeutics stock with buy rating - Investing.com
Stifel initiates Seaport Therapeutics stock with buy rating By Investing.com - Investing.com India
JPMorgan initiates Seaport Therapeutics stock with overweight rating By Investing.com - Investing.com Canada
Goldman Sachs initiates Seaport Therapeutics stock coverage citing platform validation - Investing.com Australia
Seaport Therapeutics, Inc. Common Stock (SPTX) Competitors - Meyka
Seaport Therapeutics, Inc. Common Stock (SPTX) Fundamental Analysis - Meyka
IPO Tracker 2026: Parabilis follows hefty Regeneron deal with IPO push - BioSpace
Why Is Seaport Therapeutics, Inc. Common Stock (SPTX) Stock Up Today? - Meyka
Why Is Seaport Therapeutics, Inc. Common Stock (SPTX) Stock Down Today? - Meyka
Seaport, Hemab price upsized IPOs, eyeing $550M in proceeds - MSN
Hemab, Seaport surge as clinical-stage biotechs make trading debuts - MSN
SPTX SEC FilingsSEAPORT THERAPEUTICS INC 10-K, 10-Q, 8-K Forms - Stock Titan
General Atlantic Discloses Investment at Seaport Therapeutics with 11.5% Stake - TradingView
Seaport Therapeutics (SPTX) Stock Trends and Sentiment 2026 - MarketBeat
Number of shareholders of Seaport Therapeutics, Inc. – NASDAQ:SPTX - TradingView
Seaport Therapeutics (SPTX) Stock Analysis Report | Financials & Insights - Benzinga
SPTX News Today | Why did Seaport Therapeutics stock drop today? - MarketBeat
Seaport Therapeutics set for Nasdaq debut after raising $255 million in IPO - MSN
Seaport Therapeutics Inc. (SPTX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
What is the current Price Target and Forecast for Seaport Therapeutics, Inc (SPTX) - Zacks Investment Research
Biotech firm Odyssey raises $279 million in upsized US IPO - 93.3 The Drive
Seaport Therapeutics Stock Price Today | NASDAQ: SPTX Live - Investing.com
The Readout LOUD Podcast Discusses Seaport Therapeutics’ IPO and Obesity Pill Competition on May 7, 2026 - geneonline.com
SPTX: Seaport Therapeutics, IncBrokerage Recommendations Chart - Zacks Investment Research
PureTech-linked entities convert Seaport Therapeutics (SPTX) preferred shares to common - Stock Titan
Seaport Therapeutics, Inc (SPTX) Book Value (Per Share) - Zacks Investment Research
symbol__ Stock Quote Price and Forecast - CNN
Seaport Therapeutics (SPTX) Stock Price, News & Analysis - MarketBeat
SPTX | Seaport Therapeutics, Inc. Common Institutional Ownership - Quiver Quantitative
SPTX | Seaport Therapeutics, Inc. Common Insider Trading - Quiver Quantitative
Diluted earnings per share (diluted EPS) of Seaport Therapeutics, Inc. – NASDAQ:SPTX - TradingView
SPTX | Seaport Therapeutics, Inc. Common Stock Data, Price & News - Quiver Quantitative
Seaport Therapeutics, Inc (SPTX) Stock Price Today & Analysis - Gotrade
SPTX Stock: Price, Forecast, Financials & AI Analysis - Intellectia AI
Number of employees of Seaport Therapeutics, Inc. – NASDAQ:SPTX - TradingView
Some Extraordinary Numbers From Earnings Season - Bloomberg.com
SPTX Technical Analysis & Stock Price Forecast - Intellectia AI
Seaport Therapeutics (SPTX) Stock Chart and Price History 2026 - MarketBeat
Seaport Therapeutics (SPTX) 10K Form and Latest SEC Filings 2026 - MarketBeat
Diluted earnings per share (diluted EPS) of Seaport Therapeutics, Inc. – BOATS:SPTX - TradingView
Seaport Therapeutics, Inc (SPTX) - Zacks Investment Research
Finanzdaten der Seaport Therapeutics Inc-Aktie (SPTX)
Es liegen keine Finanzdaten für Seaport Therapeutics Inc (SPTX) vor. Überprüfen Sie andere Aktien für weitere Informationen.
Umsatz
Nettogewinn
Free Cashflow
ENV
2.25%
0.46%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):